DAOA antisense RNA 1 (non-protein coding) (DAOA-AS1)

DAOA antisense RNA 1 (DAOA-AS1) is an endogenous long non-coding RNA transcribed in the antisense direction relative to the DAOA gene locus. As a natural antisense transcript (NAT), DAOA-AS1 is hypothesized, like other NATs, to regulate the expression of its associated sense gene (DAOA) and potentially influence chromatin architecture, RNA splicing, translation, and gene silencing through a variety of mechanisms such as transcriptional interference (collision of RNA polymerase), RNA:RNA duplex formation, or RNA masking[2][3]. NATs can act locally (cis) or on distant loci (trans) and are recognized as important regulators of gene expression in eukaryotic genomes[2][3]. No evidence currently suggests DAOA-AS1 encodes any protein product, nor that it serves as a direct therapeutic target or biomarker. Its function may ultimately relate to fine-tuning or buffering of DAOA expression, but this remains insufficiently proven for DAOA-AS1 specifically in current literature. No drugs specifically target DAOA-AS1 or have clinically relevant interactions with this RNA. There are no known biomarkers or safety concerns associated with DAOA-AS1. It falls into the class of "Other" molecular classifications as a non-coding, regulatory RNA[2][3].

Other names

G30G30 transcriptDAOA-ASDAOAASputative protein LG30

Not drug-targetable; possible mechanistic roles include transcriptional interference, RNA masking, or involvement in regulation of the DAOA gene (see below)[2][3]